nDatalyze Corp · CSE:NDAT

nDatalyze — Fact Sheet (October 2021)

4 slides from nDatalyze's fact sheet, October 2021

  1. Slide 1: Capitalization and company overview

    www.ndatalyze.com CAPITALIZATION (October, 2021) Issued & Outstanding: 36,921,425 • includes 9,075,000 - .20 cent Units - consisting of (1 share &1 warrant) sold by non-brokered private placement in March 2021. The warrants strike at $0.35 - expiring March 2022. There is a warrant exercise accelerat

  2. Slide 2: mHealth market size and deals

    mHealth market size and deals: $50B growing to $150B in 7 years. 23&me has entered a financing deal that values it at $3.5 billion. Google bought FitBit for $2.1 billion. These prices are based largely on the data these companies have. The global mHealth market size is projected to grow from $53 bil

  3. Slide 3: MLdelic, management experience and revenue sources

    MLdelic (www.mldelic.com) - a business-to-business predictive tool for the identification of probable mental illness that may be used to help determine the potential effect of entheogenics on the identified mental illnesses. For researchers, application developers, clinicians, insurance companies. R

  4. Slide 4: Contact: Jim Durward

    Medxtractor holds US and Canadian patents on its CO2 process. www.ndatalyze.com Contact: Jim Durward President (403) 689-3901 [email protected]

nDatalyze — Fact Sheet (October 2021) on 6ix